For­mer FDA No. 2 Amy Aber­nethy re­joins Robert Califf at Google's Ver­i­ly, hop­ping aboard as clin­i­cal R&D head

Google’s life sci­ences com­pa­ny Ver­i­ly on Thurs­day tapped for­mer prin­ci­pal deputy FDA com­mis­sion­er Amy Aber­nethy as pres­i­dent of its clin­i­cal re­search busi­ness.

The move means Aber­nethy, who left the FDA at the end of April, will join fel­low FDA alum and for­mer com­mis­sion­er Robert Califf, who serves as head of Ver­i­ly’s clin­i­cal pol­i­cy and strat­e­gy. Both Aber­nethy and Califf al­so pre­vi­ous­ly taught at Duke Uni­ver­si­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER